Advancing Cancer Diagnostics: Technologies for Quantifying the Particle Concentration of Extracellular Vesicles in...

Area of Science:

• Oncology
• Biotechnology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) are crucial mediators in cancer biology, reflecting their parent cells' molecular profiles.
• Increased EV release by tumor cells makes their particle concentration a potential biomarker for cancer diagnostics.
• Current EV quantification methods face challenges due to EV size, heterogeneity, and complex properties.

Purpose of the Study:

• To comprehensively evaluate the latest technological advancements in quantifying extracellular vesicle (EV) particle concentration.
• To highlight the principles, benefits, and limitations of current EV quantification strategies.
• To identify key challenges and drive innovation in EV-based cancer diagnostics.

Main Methods:

• Review of state-of-the-art assays for EV quantification.
• Analysis of strategies leveraging EV size, optical properties, and surface protein markers.
• Evaluation of technological advances in measuring EV particle concentration.

Main Results:

• Current EV quantification methods are limited by EV nanoscale size, heterogeneity, and physicochemical properties.
• Emerging strategies exploit EV size, optical properties, and surface markers for improved detection.
• Significant progress has been made in developing advanced EV quantification technologies.

Conclusions:

• Accurate, scalable, and clinically adaptable EV particle quantification platforms are essential for next-generation non-invasive cancer diagnostics.
• This review serves as a resource for researchers to accelerate the clinical translation of EV-based technologies.
• Advancements in EV quantification promise to transform early cancer detection and disease monitoring.